The Association Between Prolactin Levels and Cognitive Function in Female Patients With Severe Mental Disorders
6
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Cognition impairments are considered as a fundamental characteristic of severe mental disorders (SMD). Recent studies suggest that hyperprolactinemia may exert a detrimental influence on cognitive performance in patients with SMD. The objective of this study was to investigate the correlation between serum prolactin levels and cognitive function in female individuals diagnosed with SMD.Methods We conducted a study on 294 patients with SMD and 195 healthy controls, aged between 14 to 55 years old. Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), while prolactin levels were measured in serum. Descriptive analysis and comparative analysis were performed to compare cognitive function and prolactin levels between groups, and linear regression models were used to explore the relationship between prolactin and cognitive function.Results Compared to the healthy control, individuals with SMD exhibited significantly higher levels of prolactin, while scoring lower on RBANS total and every index scores. Furthermore, a negative association between prolactin levels and cognitive function (RBANS total index score, attention, and delayed memory) was observed in SMD patients. Importantly, this inverse correlation between prolactin and cognition function (RBANS total index score, total scale score, and attention) persisted in patients who were not taking medications that could potentially influence serum prolactin levels.Conclusion Our study reveals a significant correlation between elevated prolactin levels and cognitive impairment in female patients with SMD, underscoring the importance of monitoring prolactin levels in order to prevent cognitive deterioration among female SMD patients.
Abstract
Objective Cognition impairments are considered as a fundamental characteristic of severe mental disorders (SMD). Recent studies suggest that hyperprolactinemia may exert a detrimental influence on cognitive performance in patients with SMD. The objective of this study was to investigate the correlation between serum prolactin levels and cognitive function in female individuals diagnosed with SMD.Methods We conducted a study on 294 patients with SMD and 195 healthy controls, aged between 14 to 55 years old. Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), while prolactin levels were measured in serum. Descriptive analysis and comparative analysis were performed to compare cognitive function and prolactin levels between groups, and linear regression models were used to explore the relationship between prolactin and cognitive function.Results Compared to the healthy control, individuals with SMD exhibited significantly higher levels of prolactin, while scoring lower on RBANS total and every index scores. Furthermore, a negative association between prolactin levels and cognitive function (RBANS total index score, attention, and delayed memory) was observed in SMD patients. Importantly, this inverse correlation between prolactin and cognition function (RBANS total index score, total scale score, and attention) persisted in patients who were not taking medications that could potentially influence serum prolactin levels.Conclusion Our study reveals a significant correlation between elevated prolactin levels and cognitive impairment in female patients with SMD, underscoring the importance of monitoring prolactin levels in order to prevent cognitive deterioration among female SMD patients.
참고문헌 (27)
- Ali S, "Excess mortality in severe mental disorders : a systematic review and meta-regression", J Psychiatr Res, 149, pp.97~105 (2022)
- Sullivan PF, "Genetic architectures of psychi atric disorders : the emerging picture and its implications", Nat Rev Genet, 13, pp.537~551 (2012)
- Pearlson GD, "Does biology transcend the symptom-based boundaries of psychosis?", Psychiatr Clin North Am, 39, pp.165~174 (2016)
- Green MF, "What are the functional consequences of neurocognitive deficits in schizophrenia?", Am J Psychiatry, 153, pp.321~330 (1996)
- Daban C, "Specificity of cognitive deficits in bi polar disorder versus schizophrenia : a systematic review", Psychother Psychosom, 75, pp.72~84 (2006)
- Burdick KE, "Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year fol low-up", Acta Psychiatr Scand, 122, pp.499~506 (2010)
- Morrens M, "The relationship between immune and cognitive dysfunction in mood and psychotic disorder : a systematic review and a meta-analysis", Mol Psychiatry, 27, pp.3237~3246 (2022)
- Henry JF, "Hormones and cognitive functioning during late pregnancy and postpartum : a longitudinal study", Behav Neurosci, 126, pp.73~85 (2012)
- Zverova M, "Interplay between the APOE genotype and possible plasma bio markers in Alzheimer’s disease", Curr Alzheimer Res, 15, pp.938~950 (2018)
- Chen A, "Hyperprolactinemia associated with attentional processing and interference control impair ments in patients with prolactinomas", Brain Sci, 12, pp.1091~ (2022)
- Montalvo I, "Increased prolactin levels are associated with impaired process ing speed in subjects with early psychosis", PLoS One, 9, pp.e89428~ (2014)
- Montalvo I, "Sex differences in the relationship between prolactin levels and impaired processing speed in early psychosis", Aust N Z J Psychiatry, 52, pp.585~595 (2018)
- Josimovich JB, "Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication", Fertil Steril, 47, pp.785~791 (1987)
- Bolyakov A, "Prolactin in men’s health and disease", Curr Opin Urol, 21, pp.527~534 (2011)
- Meng X, "Secular trend of age at menarche in Chinese adolescents born from 1973 to 2004", Pediatrics, 140, pp.e20170085~ (2017)
- Zhang X, "Review of mendelian randomization studies on age at natural menopause", Front Endocrinol(Lausanne), 14, pp.1234324~ (2023)
- Randolph C, "The repeatable battery for the assessment of neuropsychological Status(RBANS) : preliminary clinical validity", J Clin Exp Neuropsychol, 20, pp.310~319 (1998)
- Peuskens J, "The effects of novel and new ly approved antipsychotics on serum prolactin levels : a comprehensive review", CNS Drugs, 28, pp.421~453 (2014)
- Lynham AJ, "Examining cognition across the bipolar", schizophrenia diag nostic spectrum, 2018, pp.43, 170076~
- Sæther LS, "Inflammation and cognition in severe mental illness : patterns of co variation and subgroups", Mol Psychiatry, 28, pp.1284~1292 (2023)
- Riecher-Rössler A, "Hyperprolactinemia in antipsychotic-naive patients with f irst-episode psychosis", Psychol Med, 43, pp.2571~2582 (2013)
- Ittig S, "Sex differences in prolactin levels in emerging psychosis : indication for enhanced stress reactivity in women", Schizophr Res, 189, pp.111~116 (2017)
- Inder WJ, "Antipsychotic-induced hyperprolactinaemia", Aust N Z J Psychiatry, 45, pp.830~837 (2011)
- Riecher-Rössler A, "Oestrogens, prolactin, hypothalamic-pituitary-go nadal axis, and schizophrenic psychoses", Lancet Psychiatry, 4, pp.6372~ (2017)
- Yao S, "Cognitive func tion and serum hormone levels are associated with gray matter volume decline in female patients with prolactinomas", Front Neurol, 8, pp.742~ (2018)
- Montalvo I, "Improvement in cognitive abilities following cabergoline treatment in patients with a prolactin-secreting pituitary adenoma", Int Clin Psychopharmacol, 33, pp.98~102 (2018)
- Torner L, "Actions of prolactin in the brain : from physiological adapta tions to stress and neurogenesis to psychopathology", Front Endocrinol(Lausanne), 7, pp.25~ (2016)